HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianfeng Chen Selected Research

disalicylaldehyde ethylenediamine (salen)

3/2022Stable high-oxidation-state complex in situ Mn(V)-Mn(III) transition to achieve highly efficient cervical cancer therapy.
11/2020A Gallium(III) Complex that Engages Protein Disulfide Isomerase A3 (PDIA3) as an Anticancer Target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianfeng Chen Research Topics

Disease

158Neoplasms (Cancer)
06/2022 - 02/2008
18Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 03/2009
14Breast Neoplasms (Breast Cancer)
03/2022 - 03/2009
13Melanoma (Melanoma, Malignant)
01/2022 - 02/2008
11Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2022 - 01/2014
10Hepatocellular Carcinoma (Hepatoma)
01/2019 - 02/2008
8Glioma (Gliomas)
02/2019 - 01/2014
7Glioblastoma (Glioblastoma Multiforme)
01/2019 - 03/2016
6Neoplasm Metastasis (Metastasis)
03/2022 - 03/2015
5Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 12/2015
5Inflammation (Inflammations)
10/2021 - 03/2017
5Lung Neoplasms (Lung Cancer)
01/2021 - 02/2012
5Hemolysis
10/2018 - 06/2008
4Liver Neoplasms (Liver Cancer)
01/2018 - 01/2012
3Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 01/2019
3Triple Negative Breast Neoplasms
03/2022 - 01/2020
3Hyperthermia
07/2021 - 04/2018
3Insulinoma
01/2020 - 04/2011
3Carcinoma (Carcinomatosis)
07/2016 - 06/2012
3Type 2 Diabetes Mellitus (MODY)
11/2014 - 04/2011
3Adenocarcinoma
01/2014 - 11/2008
2Rupture
03/2022 - 07/2020
2Hypoxia (Hypoxemia)
03/2022 - 09/2021
2Colonic Neoplasms (Colon Cancer)
12/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

48SeleniumIBA
06/2022 - 06/2008
33Pharmaceutical PreparationsIBA
12/2022 - 01/2012
24RutheniumIBA
01/2022 - 02/2010
17Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 02/2009
15LigandsIBA
01/2022 - 07/2010
15CaspasesIBA
01/2022 - 03/2009
13Proteins (Proteins, Gene)FDA Link
12/2022 - 10/2013
10Peptides (Polypeptides)IBA
01/2021 - 09/2014
10Cisplatin (Platino)FDA LinkGeneric
11/2020 - 07/2010
9AntioxidantsIBA
06/2022 - 06/2008
9Coordination ComplexesIBA
03/2022 - 08/2014
9Silicon Dioxide (Silica)FDA LinkGeneric
03/2022 - 11/2014
9MetalsIBA
01/2022 - 07/2010
9DNA (Deoxyribonucleic Acid)IBA
08/2018 - 01/2012
8Folic Acid (Vitamin M)FDA LinkGeneric
07/2021 - 01/2014
8Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021 - 09/2013
8selenocystineIBA
01/2020 - 11/2008
7Therapeutic UsesIBA
03/2022 - 05/2014
7GoldIBA
12/2021 - 11/2014
7IntegrinsIBA
01/2021 - 08/2014
7Polysaccharides (Glycans)IBA
07/2020 - 11/2008
7arginyl-glycyl-aspartic acidIBA
01/2019 - 08/2015
7AcidsIBA
11/2018 - 06/2008
6PolymersIBA
01/2022 - 12/2015
6Death Domain ReceptorsIBA
07/2021 - 02/2012
6IronIBA
11/2020 - 06/2015
6Antineoplastic Agents (Antineoplastics)IBA
11/2019 - 11/2012
6PhenanthrolinesIBA
12/2017 - 04/2014
5Free RadicalsIBA
01/2022 - 06/2008
5ProdrugsIBA
12/2021 - 11/2018
5isoborneol (borneol)IBA
10/2020 - 01/2013
5LipidsIBA
08/2020 - 09/2013
5Thioredoxin-Disulfide ReductaseIBA
12/2017 - 01/2013
5Superoxides (Superoxide)IBA
04/2016 - 06/2008
5PhosphatidylserinesIBA
01/2013 - 11/2008
4Biological ProductsIBA
12/2022 - 08/2014
4Biotin (Vitamin H)FDA Link
03/2022 - 07/2016
4Phosphorus (Red Phosphorus)IBA
07/2021 - 01/2018
4IridiumIBA
02/2021 - 01/2020
4Drug CarriersIBA
12/2017 - 09/2014
4PhycocyaninIBA
06/2017 - 06/2008
4ChitosanIBA
02/2017 - 08/2012
3Selenoproteins (Selenoprotein)IBA
06/2022 - 01/2021
3Glutathione (Reduced Glutathione)IBA
06/2022 - 12/2018
3Indicators and Reagents (Reagents)IBA
01/2021 - 08/2015
3Caspase 3 (Caspase-3)IBA
07/2020 - 03/2011
3Contrast MediaIBA
01/2020 - 01/2018
3Insulin (Novolin)FDA Link
11/2019 - 04/2011
3Cell-Penetrating PeptidesIBA
02/2019 - 05/2015
3ClathrinIBA
08/2018 - 09/2013
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2018 - 03/2009
3Radiation-Sensitizing AgentsIBA
08/2017 - 09/2014
3PlatinumIBA
01/2017 - 11/2014
3Transferrin (beta 2 Transferrin)IBA
01/2017 - 05/2015
3Islet Amyloid PolypeptideIBA
11/2014 - 04/2011
2HydrogelsIBA
12/2022 - 07/2015
2disalicylaldehyde ethylenediamine (salen)IBA
03/2022 - 11/2020
2Oxygen (Dioxygen)IBA
03/2022 - 01/2022
2AntigensIBA
01/2022 - 10/2020
2EstersIBA
01/2022 - 03/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2016
2TelluriumIBA
12/2021 - 03/2021
2Urokinase Plasminogen Activator ReceptorsIBA
10/2021 - 10/2019
2CytokinesIBA
10/2021 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
10/2020 - 03/2019
2Palmitic Acid (Hexadecanoic Acid)IBA
01/2020 - 06/2017

Therapy/Procedure

73Therapeutics
03/2022 - 07/2010
27Drug Therapy (Chemotherapy)
06/2022 - 07/2010
23Radiotherapy
01/2022 - 01/2013
14Precision Medicine
03/2022 - 09/2014
8Immunotherapy
06/2022 - 10/2019
7Photothermal Therapy
01/2022 - 11/2016
6Lasers (Laser)
03/2022 - 04/2018
5Chemoradiotherapy
02/2021 - 01/2017
4Chemoprevention
03/2015 - 06/2008
3Photochemotherapy (Photodynamic Therapy)
12/2021 - 01/2018